Physician profile
Daniel E Levin
NPI 1639108269
$1,774.82
in general payments reported to CMS, 2019-2025
17 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $290 · 2021: $403 · 2022: $260 · 2023: $284 · 2024: $127 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $778.54 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $241.97 | 2021-2023 | |
| Therapeuticsmd, INC. | $208.26 | 2019-2022 | |
| Exeltis, USA INC. | $111.00 | 2020-2022 | |
| Evofem Biosciences, INC. | $78.73 | 2024-2025 | Phexxi, Solosec, Phexx |
| Collegium Pharmaceutical, INC. | $75.09 | 2025 | Belbuca, Xtampza |
| Allergan, INC. | $65.21 | 2019 | |
| Hologic Sales and Service, LLC | $47.84 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $28.75 | 2024 | |
| Avion Pharmaceuticals | $27.42 | 2019-2020 | |
| Avanos Medical | $20.91 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.38 | 2019 | |
| Coopersurgical, INC. | $16.44 | 2024 | Paragard T 380a |
| Lupin INC. | $15.12 | 2020 | |
| Organon LLC | $13.98 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $13.33 | 2019 | |
| Ethicon US, LLC | $11.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.